VJOncology is committed to improving our service to you

ESMO 2020 | FLIPPER trial: an update

VJOncology is committed to improving our service to you

Joan Albanell

Joan Albanell, MD, Pompeu Fabra University, Barcelona, Spain, discusses the results from the FLIPPER trial (NCT02690480). The FLIPPER trial is a randomized Phase II study that investigated the efficacy of fulvestrant plus palbociclib vs fulvestrant plus placebo in postmenopausal women with hormone receptor positive (HR+)/HER2 negative (HER2–) endocrine-sensitive advanced breast cancer (ABC). This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter